Several groups explored this strategy to establish transgenic models for the PML-RARA fusion gene resulting from the t(15;17)(q24;q21) chromosomal translocation present in the vast majority of patients with acute promyelocytic leukaemia (APL). This evidence concerns the gene PML and acute promyelocytic leukemia.